These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17653309)

  • 1. [Effect of hepatitis C virus serotype on the response of patients with chronic hepatitis C to interferon treatment].
    Chen LJ; Li MH; Xie Y; Xu DZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):117-9. PubMed ID: 17653309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
    Kawai S; Yokosuka O; Imazeki F; Saisho H; Mizuno C
    J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA.
    Shiratori Y; Yokosuka O; Nakata R; Ihori M; Hirota K; Katamoto T; Unuma T; Okano K; Ikeda Y; Hirano M; Kawase T; Takano S; Matsumoto K; Ohashi Y; Omata M
    Hepatology; 1999 May; 29(5):1573-80. PubMed ID: 10216145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of combined interferon-ribavirin in the treatment of chronic hepatitis C.
    Muhammad N; Jan MA; Rahman N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):651-3. PubMed ID: 15530272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twice-a-day versus once-a-day interferon-beta therapy in chronic hepatitis C.
    Kaito M; Yasui-Kawamura N; Iwasa M; Kobayashi Y; Nakagawa N; Fujita N; Ikoma J; Gabazza EC; Watanabe S; Adachi Y
    Hepatogastroenterology; 2003; 50(51):775-8. PubMed ID: 12828083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
    Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with interferon alpha and beta to chronic hepatitis C.
    Horiike N; Hino H; Tanaka Y; Miyaoka H; Miki S; Yamashita S; Matsuura B; Kubo Y; Ikeda Y; Akbar SM; Masumoto T; Michitaka K; Onji M
    Oncol Rep; 2003; 10(1):157-61. PubMed ID: 12469163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
    Xu DZ; Xie Y; Li ZQ
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of clinical usefulness of second-generation HCV core antigen assay: comparison with COBAS AMPLICOR HCV MONITOR assay version 2.0.
    Yokosuka O; Kawai S; Suzuki Y; Fukai K; Imazeki F; Kanda T; Tada M; Mikata R; Hata A; Saisho H
    Liver Int; 2005 Dec; 25(6):1136-41. PubMed ID: 16343063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concordance between hepatitis C virus serotype and genotype in chronic hepatitis C patients in China].
    Zhao H; Li MH; Xie Y; Du SC; Xu DZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):355-7. PubMed ID: 18322601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial.
    Nomura H; Sou S; Tanimoto H; Nagahama T; Kimura Y; Hayashi J; Ishibashi H; Kashiwagi S
    Hepatology; 2004 May; 39(5):1213-9. PubMed ID: 15122749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necessities of interferon therapy in elderly patients with chronic hepatitis C.
    Ikeda K; Arase Y; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Kumada H
    Am J Med; 2009 May; 122(5):479-86. PubMed ID: 19375558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.
    Orlent H; Hansen BE; Willems M; Brouwer JT; Huber R; Kullak-Ublick GA; Gerken G; Zeuzem S; Nevens F; Tielemans WC; Zondervan PE; Lagging M; Westin J; Schalm SW
    J Hepatol; 2006 Oct; 45(4):539-46. PubMed ID: 16905220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.
    Moreno M; Pérez-Alvarez R; Rodrigo L; Pérez-López R; Suárez-Leiva P
    J Viral Hepat; 2006 Jan; 13(1):28-33. PubMed ID: 16364079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HCV-serotype and IFN response].
    Nakamura H; Kako M; Aikawa T; Mayumi M; Kanai K
    Nihon Rinsho; 1994 Jul; 52(7):1734-7. PubMed ID: 7521412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia in patients with HCV-positive chronic hepatitis: efficacy of leucocyte interferon-alpha treatment.
    Benci A; Caremani M; Tacconi D
    Int J Clin Pract; 2003; 57(1):17-9. PubMed ID: 12587936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.